---
title: Cure US/China
---

[Skip to main content](https://hs.cureexperience.com/cure-us-china#pox-main)

[![logo-white.svg fill](https://hs.cureexperience.com/hubfs/logo-white.svg%20fill.png)](https://hs.cureexperience.com/cure-us-china)

![Group 2](https://hs.cureexperience.com/hubfs/Group%202.png)

Original research on how 303 US institutions turn discoveries into real-world health impact

Live webinar

# Racing to Cures: The US/China Biomedical Competitiveness Scorecard

The US leads China in scientific quality and commercial depth. China leads in speed, scale, and cost. Here's the full data behind the race.

![Group 72](https://hs.cureexperience.com/hubfs/Group%2072.png)

## Why download

- ### For VPs of Research & Provosts
  
    - See the full 35-metric scorecard across six domains, and exactly where your institution's translational performance stacks up against a faster-moving global competitor
    - The US holds a 31% scientific influence advantage. Find out how long the data says that lead will last without structural investment
- ### For TTO Directors
  
    - Why China's discovery-to-IND cycles run 50–70% faster, and what that means for how fast US institutions need to move deals from lab to industry
    - The 64:1 translational bottleneck: see whether your institution's infrastructure puts you in the fast lane or the slow one
- ### For Presidents & Institutional Leadership
  
    - What senior industry leaders say is hardest to replicate on each side, and why complacency, not China's progress, is named as the bigger risk
    - Five specific moves the data says the US needs to make now, and what happens by 2031 if it doesn't

> "America's scientific leadership and discovery capabilities are our greatest strategic assets. Discovery alone will not secure our leadership — translation will."

Vanessa Almendro Navarro, PhD, MBA, Senior Vice President and Chief Commercialization Officer, City of Hope

[Get the Scorecard](https://downloads.ctfassets.net/ou0qvg08mzx4/7JsgEr3RXxYZCti8CzLslr/1876f69a53078b91e491d8c3171536c0/what_makes_institution_innovative_ver04A.pdf)

![](https://hs.cureexperience.com/hubfs/Group%202087331255.svg)

## About

- [Our Mission](https://wewillcure.com/about)
- [Our Team](https://wewillcure.com/community/leadership)
- [Newsroom](https://wewillcure.com/newsroom)
- [Partnerships and Sponsorships](https://wewillcure.com/partnerships)

## Get in Touch

- [Contact Us](https://wewillcure.com/contact-us)
- [Apply for Membership](https://wewillcure.com/membership)
- [Newsletters Sign-up](https://wewillcure.com/newsletter)

## Privacy

- [Privacy Policy](https://wewillcure.com/privacy-policy)
- [Terms of Use](https://wewillcure.com/terms-and-conditions)

- <https://www.linkedin.com/company/curenyc/>
- <https://www.youtube.com/@wewillcure>
- <https://www.instagram.com/wewillcure/>
- <https://twitter.com/cure345/>
- <https://www.facebook.com/CureAt345ParkAveSouth/>

© 2026 Cure Experience Services, LLC. All Rights Reserved.

[![Frame 2147227743-1](https://hs.cureexperience.com/hubfs/Frame%202147227743-1.svg)](https://hs.cureexperience.com/cure-us-china)